We describe the results of a detailed autoantibody study in a patient with anti-CNTN1 antibody-positive CIDP and MN, together with a comparison of the clinical features between CIDP with MN and anti-CNTN1 antibody-positive CIDP. This evidence concerns the gene CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy.